Abstract:Interactions among the gut microbiome, dysregulated immune responses, and genetic factors contribute to the pathogenesis of inflammatory bowel disease (IBD). Nlrx1-/- mice have exacerbated disease severity, colonic lesions, and increased inflammatory markers. Global transcriptomic analyses demonstrate enhanced mucosal antimicrobial defense response, chemokine and cytokine expression, and epithelial cell metabolism in colitic Nlrx1-/- mice compared to wild-type (WT) mice. Cell-specificity studies using cre-lox mice demonstrate that the loss of NLRX1 in intestinal epithelial cells (IEC) recapitulate the increased sensitivity to DSS colitis observed in whole body Nlrx1-/- mice. Further, organoid cultures of Nlrx1-/- and WT epithelial cells confirm the altered patterns of proliferation, amino acid metabolism, and tight junction expression. These differences in IEC behavior can impact the composition of the microbiome. Microbiome analyses demonstrate that colitogenic bacterial taxa such as Veillonella and Clostridiales are increased in abundance in Nlrx1-/- mice and in WT mice co-housed with Nlrx1-/- mice. The transfer of an Nlrx1-/--associated gut microbiome through co-housing worsens disease in WT mice confirming the contributions of the microbiome to the Nlrx1-/- phenotype. To validate NLRX1 effects on IEC metabolism mediate gut-microbiome interactions, restoration of WT glutamine metabolic profiles through either exogenous glutamine supplementation or administration of 6-diazo-5-oxo-l-norleucine abrogates differences in inflammation, microbiome, and overall disease severity in Nlrx1-/- mice. The influence NLRX1 deficiency on SIRT1-mediated effects is identified to be an upstream controller of the Nlrx1-/- phenotype in intestinal epithelial cell function and metabolism. The altered IEC function and metabolisms leads to changes in barrier permeability and microbiome interactions, in turn, promoting greater translocation and inflammation and resulting in an increased disease severity. In conclusion, NLRX1 is an immunoregulatory molecule and a candidate modulator of the interplay between mucosal inflammation, metabolism, and the gut microbiome during IBD.

Estrogen receptor β activation inhibits colitis by promoting NLRP6-mediated autophagy

Estrogen Receptor Β Activation Alleviates Inflammatory Bowel Disease by Suppressing NLRP3-dependent IL-1β Production in Macrophages Via Downregulation of Intracellular Calcium Level

Estrogen receptor α aggravates intestinal inflammation via promoting the activation of NLRP3 inflammasome

Estrogen Receptor β Activation Mitigates Colitis-associated Intestinal Fibrosis via Inhibition of TGF-β/Smad and TLR4/MyD88/NF-κB Signaling Pathways

Estrogen Receptor Β Alleviates Inflammatory Lesions in a Rat Model of Inflammatory Bowel Disease Via Down-Regulating P2X7R Expression in Macrophages

Estrogen Receptor Β Activation Ameliorates DSS-induced Chronic Colitis by Inhibiting Inflammation and Promoting Treg Differentiation.

Estrogen receptors participate in carcinogenesis signaling pathways by directly regulating NOD-like receptors.

Estrogen receptor alpha regulates the Wnt/β-catenin signaling pathway in colon cancer by targeting the NOD-like receptors

Loss of ERβ in Aging LXRαβ Knockout Mice Leads to Colitis

Erbin Exerts a Protective Effect Against Inflammatory Bowel Disease by Suppressing Autophagic Cell Death

Epithelial Ezh2 Serves As An Epigenetic Determinant In Experimental Colitis By Inhibiting Tnf Alpha-Mediated Inflammation And Apoptosis

The regulation of NLRP3 inflammasome activation by CCDC50-mediated autophagy

The REGγ-proteasome Forms a Regulatory Circuit with IκBɛ and NFκB in Experimental Colitis

Facilitation of Mucosal Healing by Estrogen Receptor Β in Ulcerative Colitis Through Suppression of Branched-Chain Amino Acid Transport and Subsequent Triggering of Autophagy in Colonic Epithelial Cells

Pharmacological Activation of ERβ by Arctigenin Maintains the Integrity of Intestinal Epithelial Barrier in Inflammatory Bowel Diseases

ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction

ER-phagy restrains inflammatory responses through its receptor UBAC2

Estrogen receptor is involved in the osteoarthritis mediated by Atg16L1-NLRP3 activation

NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease

Colitis‐induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity

Estrogen receptor β induces autophagy in colon cancer cells through modulation of AMPK/mTORC1 axis